Search

everythinglearnresearchcommunity

for

Search:↓

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Women with female-pattern baldness produce more testosterone, but 5a-reductase inhibition treatment won't help.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

The main causes of hirsutism in Jordanian women are PCOS and idiopathic hirsutism.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The book details advanced techniques in cosmetic dermatology for experienced surgeons.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Finasteride caused long-term sexual and non-sexual side effects in young men with hair loss.

Fat cells are important for tissue repair and stem cell support in various body parts.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Women with PCOS often have more sleep problems than the general population.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.